InsiderClue
← All stocks

Annexon, Inc.

ANNX Net buying
CIK 0001528115 #2555 in the set updated 17 Sep 2026
Bought (120 mo)
$67.24M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$3.16M
$129.58K on a plan · $2.39M straight out of an exercise
Sold at will
$633.58K
39 of 68 sales
Net
+$64.08M
+$66.61M against sales at will

By person

15 insiders · 110 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Satter Muneer A
Director
$43.81M (10)
—
+$43.81M
12,297,112
8.23%
$66.53M
+529.0%
Flynn James E
10% owner
$11.90M (2)
—
+$11.90M
1,617,828
1.08%
$8.75M
—
Bain Capital Life Sciences Investors, LLC entity
10% owner
$7.44M (2)
—
+$7.44M
8,943,554
5.99%
$48.38M
+65.6%
Clarus Lifesciences III, L.P.
10% owner
$3.40M (1)
—
+$3.40M
2,730,635
1.83%
$14.77M
—
Yednock Ted
EVP & CHIEF INNOVATION OFFICER
—
$1.51M (20) scheduled
−$1.51M
184,807
0.1237%
$999.81K
+213.8%
Love Douglas
PRESIDENT AND CEO
$146.81K (1)
$819.94K (14) scheduled
−$673.13K
351,554
0.2354%
$1.90M
+2,162%
Lew Jennifer
EVP & CHIEF FINANCIAL OFFICER
$34.00K (1)
$435.82K (16) scheduled
−$401.82K
170,700
0.1143%
$923.49K
+1,204%
Carson William H.
Director
$374.09K (18)
—
+$374.09K
78,405
0.0525%
$424.17K
—
Choi Jung
Director
$138.27K (1)
—
+$138.27K
33,000
0.0221%
$178.53K
—
Keswani Sanjay Chandru
EVP & Chief Medical Officer
—
$120.51K (1) scheduled
−$120.51K
12,500
0.0084%
$67.63K
—
Overdorf Michael
EVP & CHIEF BUSINESS OFFICER
—
$118.27K (11)
−$118.27K
182,625
0.1223%
$988.00K
+750.2%
ARTIS DEAN RICHARD
EVP & CHIEF SCIENTIFIC OFFICER
—
$75.36K (3)
−$75.36K
180,093
0.1206%
$974.30K
+257.8%
Dananberg Jamie
CHIEF MEDICAL OFFICER
—
$74.92K (3)
−$74.92K
123,582
0.0827%
$668.58K
—
Redmile Group, LLC entity
10% owner
—
—
—
1,596,222
1.07%
$8.64M
—
Mattheakis Larry
EVP & Chief Scientific Officer
—
—
—
17,188
0.0115%
$92.99K
—

Individual transactions

25
Insider
Date
Role
Action
Shares
Price
Amount
Yednock Ted
15 Oct 2024
EVP & CHIEF INNOVATION OFFICER
Sold after exercise
5,408
$7.41
$40.07K
Yednock Ted
27 Dec 2023
EVP & Chief Innovation Officer
Sold after exercise
21,000
$4.52
$94.97K
Love Douglas
16 Sep 2021
President & CEO
Sold after exercise
7,500
$22.05
$165.34K
Lew Jennifer
13 Sep 2021
EVP & Chief Financial Officer
Sold after exercise
3,500
$20.01
$70.03K
Yednock Ted
13 Sep 2021
EVP & Chief Scientific Officer
Sold after exercise
16,190
$20.00
$323.86K
Love Douglas
8 Jun 2021
President & CEO
Sold after exercise
3,750
$22.55
$84.56K
Love Douglas
7 Jun 2021
President & CEO
Sold after exercise
3,750
$22.31
$83.67K
Yednock Ted
3 Jun 2021
EVP & Chief Scientific Officer
Sold after exercise
2,184
$21.72
$47.44K
Yednock Ted
3 Jun 2021
EVP & Chief Scientific Officer
Sold after exercise
12,816
$21.45
$274.88K
Lew Jennifer
27 May 2021
EVP & Chief Financial Officer
Sold after exercise
3,500
$22.24
$77.84K
Love Douglas
1 Apr 2021
President & CEO
Sold after exercise
300
$28.01
$8.40K
Love Douglas
1 Apr 2021
President & CEO
Sold after exercise
200
$28.19
$5.64K
Love Douglas
31 Mar 2021
President & CEO
Sold after exercise
7,102
$28.11
$199.62K
Love Douglas
30 Mar 2021
President & CEO
Sold after exercise
1,850
$24.78
$45.85K
Love Douglas
30 Mar 2021
President & CEO
Sold after exercise
1,900
$24.27
$46.12K
Love Douglas
29 Mar 2021
President & CEO
Sold after exercise
300
$27.24
$8.17K
Love Douglas
29 Mar 2021
President & CEO
Sold after exercise
600
$26.42
$15.85K
Love Douglas
29 Mar 2021
President & CEO
Sold after exercise
2,850
$25.02
$71.31K
Yednock Ted
25 Mar 2021
EVP & Chief Scientific Officer
Sold after exercise
237
$29.96
$7.10K
Yednock Ted
25 Mar 2021
EVP & Chief Scientific Officer
Sold after exercise
5,680
$29.21
$165.91K
Yednock Ted
25 Mar 2021
EVP & Chief Scientific Officer
Sold after exercise
10,258
$28.54
$292.76K
Keswani Sanjay Chandru
24 Mar 2021
EVP & Chief Medical Officer
Sold after exercise
3,995
$30.17
$120.51K
Lew Jennifer
23 Mar 2021
EVP & Chief Financial Officer
Sold after exercise
1,800
$29.16
$52.49K
Lew Jennifer
23 Mar 2021
EVP & Chief Financial Officer
Sold after exercise
1,800
$28.43
$51.17K
Lew Jennifer
23 Mar 2021
EVP & Chief Financial Officer
Sold after exercise
1,400
$27.51
$38.51K
Show all 110 transactions →

What was left out

Form 4 filings counted 171
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 25
Sales at will 39
Transactions with no price 0
Shares from compensation/vesting 10,927,333
Sales filed before the plan box existed 5
History held since 24 Jul 2020